Karmanos Cancer Institute (Barbara Ann Karmanos Cancer Hospital)

Detroit, Michigan 48201

1 studies enrolling now · 3 studies all time

What they study most

EGFRm Advanced Non-Small Cell Lung Cancer, EGFRm Metastatic Non-Small Cell Lung Cancer, Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung Cancer, Metastatic Pancreas Adenocarcinoma, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic, Pancreatic Adenosquamous Carcinoma, Pancreatic Cancer, Pancreatic Cancer Metastatic

Studies at this site

• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• Medical Access Program for Datopotamab Deruxtecan in EGFRm NSCLC Patients — APPROVED_FOR_MARKETING
• Medical Access Program for Patritumab Deruxtecan — NO_LONGER_AVAILABLE